Evidence map›Paper›PMID 39886087›Full record

ArticleJournal of global infectious diseases

IgM against Merozoite Surface Protein 1-Block 2 Haplotypes as New Tools for

Fernanda de Almeida Batalha, Elizangela Farias da Silva, Paula Taquita Serra, Rafaella Oliveira Dos Santos, Zeca Manuel Salimo, Yury de Oliveira Chaves, Mirian Ívens Fagundes, Paulo Emílio Feuser, Victor Costa de Souza, Felipe Gomes Naveca and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of global infectious diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fernanda de Almeida BatalhaLeônidas and Maria Deane Institute, Oswaldo Cruz Foundation, Manaus, Amazonas State, Brazil.
Elizangela Farias da SilvaLeônidas and Maria Deane Institute, Oswaldo Cruz Foundation, Manaus, Amazonas State, Brazil.
Paula Taquita SerraLeônidas and Maria Deane Institute, Oswaldo Cruz Foundation, Manaus, Amazonas State, Brazil.
Rafaella Oliveira Dos SantosLeônidas and Maria Deane Institute, Oswaldo Cruz Foundation, Manaus, Amazonas State, Brazil.
Zeca Manuel SalimoPostgraduate Program in Tropical Medicine, Amazonas State University, Manaus, Amazonas State, Brazil.
Yury de Oliveira ChavesLeônidas and Maria Deane Institute, Oswaldo Cruz Foundation, Manaus, Amazonas State, Brazil.
Mirian Ívens FagundesExperimental Pathophysiology Laboratory, Universidade do Extremo Sul Catarinense, Santa Catarina, Brazil.
Paulo Emílio FeuserExperimental Pathophysiology Laboratory, Universidade do Extremo Sul Catarinense, Santa Catarina, Brazil.
Victor Costa de SouzaLeônidas and Maria Deane Institute, Oswaldo Cruz Foundation, Manaus, Amazonas State, Brazil.
Felipe Gomes NavecaPostgraduate Program in Biology of Host-Pathogen Interaction, Oswaldo Cruz Foundation Manaus, Amazonas State, Brazil.
Ricardo A Machado de ÁvilaExperimental Pathophysiology Laboratory, Universidade do Extremo Sul Catarinense, Santa Catarina, Brazil.
Paulo Afonso NogueiraLeônidas and Maria Deane Institute, Oswaldo Cruz Foundation, Manaus, Amazonas State, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The tools to distinguish relapse from reinfection are needed in malaria-endemic areas. We evaluated seroprevalence against sets of specific peptides to the block 2 region of Methods: We applied amplicon deep sequencing (ADS) of block 2 region of the MSP-1 gene ( Results: ADS revealed one block 2 haplotype clone infecting five of eight Conclusion: IgM against sets of peptides specific to different

Indexed as

Anti-block 2 merozoite surface protein 1IgMPlasmodium vivaxpregnant womanrecurrence

Identifiers

PMID39886087
PMCPMC11775398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.